<!DOCTYPE html>
<meta charset="utf8" />
<html>
<link
  rel="stylesheet"
  href="https://cdn.jsdelivr.net/npm/@picocss/pico@2/css/pico.classless.min.css"
/>
<body>
    <header>
        <nav>
            <ul>
                <li><h1>QuiVoteQuoi?</h1></li>
            </ul>
            <ul>
                <li><a href="/subjects">Sujets</a></li>
            </ul>
        </nav>
    </header>
    <main>
        <section>
            <a href="/">⟵ Retourner à la recherche</a>
            <h2>Resolution on Commission Implementing Regulation (EU) 2021/745 of 6 May 2021 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances aluminium ammonium sulphate, aluminium silicate, beflubutamid, benthiavalicarb, bifenazate, boscalid, calcium carbonate, captan, carbon dioxide, cymoxanil, dimethomorph, ethephon, extract from tea tree, famoxadone, fat distillation residues, fatty acids C7 to C20, flumioxazine, fluoxastrobin, flurochloridone, folpet, formetanate, gibberellic acid, gibberellins, heptamaloxyloglucan, hydrolysed proteins, iron sulphate, metazachlor, metribuzin, milbemectin, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos-methyl, plant oils/rape seed oil, potassium hydrogen carbonate, propamocarb, prothioconazole, quartz sand, fish oil, repellents by smell of animal or plant origin/sheep fat, S-metolachlor, Straight Chain Lepidopteran Pheromones, tebuconazole and urea</h2>
            <h3>Sujets</h3>
            <ul>
                
                    
                    <li><a href="/subject/3.10.09">Phytosanitaire, phytopharmacie, agriculture biologique, agro-génétique: généralités</a></li>
                
            </ul>
            <h3>Votes</h3>
            
            <ul>
                
                <li><a href="/vote/133730">Objection au titre de l'article 112, paragraphes 2 et 3, du règlement intérieur: substances actives, dont la flumioxazine - Objection pursuant to Rule 112(2) and (3): Active substances, including flumioxazine - B9-0312/2021 - Proposition de résolution</a></li>
                
            </ul>
        </section>
    </main>
</body>
</html>